Article thumbnail

Effects of the Soluble Fiber Complex PolyGlycopleX® on Glucose Homeostasis and Body Weight in Young Zucker Diabetic Rats

By Gary James Grover, Lee Koetzner, Joan Wicks, Roland J. Gahler, Michael R. Lyon, Raylene A. Reimer and Simon Wood

Abstract

Dietary fiber can reduce insulin resistance, body weight, and hyperlipidemia depending on fiber type, water solubility, and viscosity. PolyGlycopleX® (PGX®) is a natural, novel water soluble, non-starch polysaccharide complex that with water forms a highly viscous gel compared to other naturally occurring dietary fiber. We determined the effect of dietary PGX® vs. cellulose and inulin on the early development of insulin resistance, body weight, hyperlipidemia, and glycemia-induced tissue damage in young Zucker diabetic rats (ZDFs) in fasted and non-fasted states. ZDFs (5 weeks old) were fed a diet containing 5% (wgt/wgt) cellulose, inulin, or PGX® for 8 weeks. Body weight, lipids, insulin, and glucose levels were determined throughout the study and homeostasis model assessment (HOMA) was used to measure insulin sensitivity throughout the study in fasted animals. At study termination, insulin sensitivity (oral glucose tolerance test, OGTT) and kidney, liver, and pancreatic histopathology were determined. Body weight and food intake were significantly reduced by PGX® vs. inulin and cellulose. Serum insulin in fasted and non-fasted states was significantly reduced by PGX® as was non-fasted blood glucose. Insulin resistance, measured as a HOMA score, was significantly reduced by PGX® in weeks 5 through 8 as well as terminal OGTT scores in fed and fasted states. Serum total cholesterol was also significantly reduced by PGX®. PGX® significantly reduced histological kidney and hepatic damage in addition to reduced hepatic steatosis and cholestasis. A greater mass of pancreatic β-cells was found in the PGX® group. PGX® therefore may be a useful dietary additive in the control of the development of the early development of the metabolic syndrome

Topics: Pharmacology
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3168379
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). A review of islet of Langerhans degeneration in rodent models of type 2 diabetes.
  2. (2010). An analytical ultracentrifuge study on ternary mixtures of konjac glucomannan supplementedwithsodiumalginateand xanthan gum.
  3. and Behforooz,T.(1983).Effectofglucomannan on obese patients: a clinical study.
  4. and Burdock,G.A.(2009).Supplementation of the diet with the functional fiber PolyGlycopleX® is well tolerated by healthy subjects in a clinical trial.
  5. and Riddell-Mason,S.(1994).Tendifferent dietary fibers have significantly different effects on serum and liver lipids of cholesterol-fed rats.
  6. (2000). Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.
  7. (1997). Cereals, cereal fiber and colorectal cancer risk: a review of the epidemiological literature.
  8. (2007). Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
  9. (2008). Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and highsucrose (cafeteria) diet.
  10. (1982). Comparison of the effects of highand low-methoxy pectins on blood and fecal lipids in man.
  11. (2008). Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.
  12. (2005). Dietary carbohydrates in the human GI tract: the established and emerging science.
  13. (2001). Dietary fiber and weight regulation.
  14. (2000). Dietary fiber, physicochemical Frontiers
  15. (2002). Dietary fructans, but not cellulose, decrease triglycerideaccumulationintheliver of obese Zucker fa/fa rats.
  16. (1984). Eaton RP. Dietary fiber and lipoprotein metabolism in the genetically obese Zucker rat.
  17. (2010). Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: a dose-response study in JCR: LA-cp rats.
  18. (2007). Effects of dietary fibers on weight gain, carbohydrate metabolism and gastric ghrelin gene expression in mice fed a high fat diet.
  19. (1990). Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers.
  20. (2008). Effects of lifelong intervention with an oligofructose-enriched inulin in rats on general health and lifespan.
  21. (1991). Effects of long-term high-fiber diet on macrovascular changes and lipid and glucose levels in STX-induced SD rats. Diabetes Res.
  22. (1985). Effects of nutrients and nonnutrients on food intake.
  23. (1999). Effects of psyllium on glucose and serum lipid responses in menwithtype2diabetes.Am.J.Clin.
  24. (2011). Effects of the soluble fiber complex PolyGlycopex on glycemic control, insulin secretion,andGLP-1levelsinZucker diabetic rats.
  25. (2011). Effects of the soluble fiber complex PolyGlycopleX® on glucose homeostasis and body weight in young Zucker diabetic rats.
  26. (2007). Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes Res.
  27. (1998). Enhanced glucose-dependent insulinotropic polypeptide secrtion and insulinotropic action in glucogaon-like peptide 1 receptor −/− mice.
  28. (2001). Evaluation of liver function,”
  29. (1998). Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs.
  30. (1991). Hypocholesterolemic effects of different bulk-forming hydrophilic fibers as adjunts to dietary therapy in mild to moderate hypercholesterolemia. Cholesterol-lowering effects of psylium hydrophilic mucilloid for hypercholesterolemic men.
  31. (2011). Increased plasma PYY levels following supplementation with the functional fiber PolyGlycopleX in healthy adults.
  32. (2007). Inhibition of dipeptidyl peptidase IV with sitagliptin prolongs graft survival in streptozotocin-induced diabetic mice. Diabetes 57, 1331–1339. Kim,W.,andEgan,J.M.(2008).Therole of incretins in glucose homeostasis and diabetes treatment.
  33. (2008). Liraglutide, a long acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.
  34. (2008). Metabolic effects of dietary fiber consumption and prevention of diabetes.
  35. (2011). paper pending published: 01
  36. (2010). PGX, anovelfunctionalfibre,onacuteand delayedpostprandialglycaemia.Eur.
  37. (2008). Prandial glucose regulation in the glucose triad.
  38. (1994). Psyllium husk fiber supplementation to soybean and coconut oil diets of humans: effect on fat digestibility and fecal fatty acid excretion.
  39. (2004). Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments.
  40. (2010). Studies on macromolecular interactions in ternary mixtures of konjac glucomannan, xanthan gum and sodium alginate.
  41. (2006). The benefits of early intervention in obese diabetic patients with FBCX.
  42. (2009). The safety of PolyGlycopleX®(PGX®)asshownin a 90-day rodent feeding study.
  43. (2011). The soluble fiber complex PolyGlycoplex lowers serum triglycerides and reduces hepatic steatosis in high-sucrose-fed rats.
  44. (2000). Viscous and nonviscous fibers, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease.
  45. (2009). Weight loss during oligofructose supplementation is associated with decreasedghrelinandincreasedpeptide YY in overweight and obese adults.
  46. (2007). β-Glucan from two sources of oat concentrates effect postprandial glycemia in relation to the level of viscosity.